ImmunologybioRxiv
Circulating Th17.1 cells as candidate for prediction of therapeutic response to abatacept in patients with rheumatoid arthritis: exploratory research
S. Maeda, S. Osaga, T. Maeda…·A. Niimi
This study identifies Th17.1 cells as a biomarker predicting response to abatacept in rheumatoid arthritis patients.
DOI 10.1371/journal.pone.0215192